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Case Report
Mediastinal Seminoma presenting as superior vena cava
syndrome and tracheal obstruction
Saulat Hasnain Fatimi,1 Basma Shahid,2 Hashim Muhammad Hanif,3 Marium Muzaffar4
Department of Surgery, Division of Cardiothoracic Surgery,1 Medical College,2-4 Aga Khan University, Karachi, Pakistan.

Abstract
Malignant germ cell tumours of the mediastinum
are rare, presenting mostly in young males. These are
bulky tumours, mostly intrathoracic, infiltrating into
adjacent structures early in the growth process. Patients
may present with symptoms of compression. Occasionally,
mediastinal adenopathy and superior vena cava (SVC)
syndrome may occur.
We discuss a case of a 19 year old boy with six weeks
history of progressively worsening shortness of breath and
mid-sternal chest heaviness and one month history of
swelling of the face and upper limbs. The entire face and
upper extremities were grossly oedematous with engorged
veins suggesting SVC syndrome. CT scan chest showed a
large mediastinal mass 18x24 cm extending from the superior
mediastinum to the mid pericardial area. The trachea was
extrinsically compressed to almost 80% at its distal portion.
Mass was resected completely. Post operative course was
unremarkable. The final histopathology showed a fibrotic
mass with no viable tumour. Surgery followed by radiation
therapy has been the usual initial treatment with multimodal
chemotherapy showing remarkable results.

Introduction
Primary malignant germ cell tumours of the
mediastinum are rare.1,2 Only 2-5% of germ cell tumours
occur at extra-gonadal sites.3 Seminomas are malignant germ
cell tumours that account for about 25% of all primary
mediastinal germ cell tumours.4 They are speculated to arise
in unusual locations due to migration of germ cells during
embryogenesis.5 These tumours are more common in young
males usually occurring in the third or fourth decade of life.2
Seminomas are radiosensitive tumours, yet
radiotherapy is associated with a higher risk of recurrence.
The introduction of Cisplatin based chemotherapy, as initial
treatment has greatly improved the prognosis of these
tumours.

Case Report
We present the case of a 19 year old boy presenting to
the ER, with six weeks history of progressively worsening
shortness of breath and mid-sternal chest heaviness and one
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month history of swelling of the face and upper limbs. On
examination, he was in extreme distress with tachycardia and
tachypnoea. He had an Oxygen saturation of 88% on room
air. The entire face and upper extremities were grossly
oedematous with engorged veins suggesting SVC syndrome.
Patient had a CT scan chest done, a week prior to this
presentation which showed a large mediastinal mass, 18 cm
by 24 cm, extending from the superior mediastinum to the
mid pericardial area. It was completely occluding the superior
vena cava and innominate vein. The trachea was extrinsically
compressed to almost 80% at its distal portion. An urgent
biopsy of this mass was done without anaesthesia with BIPAP
(Bi level positive airway pressure) support in the OR and
alpha feto-protein, beta HCG and LDH levels were sent.
Within 24 hours the biopsy results revealed mediastinal
seminoma. Patient was started on BEP (Bleomycin Etoposide
Cisplatin) regimen chemotherapy and within 48 hours patient
became better and was able to be discharged without any
oxygen after one week, with almost complete resolution of
his SVC syndrome and tachypnoea. Patient received six
cycles of chemotherapy after which via median sternotomy
the residual mass was resected completely. Post operative
course was unremarkable. The final histopathology showed a
fibrotic mass with no viable tumour.

Discussion
Mediastinum is the most common site for extra
gonadal germ cell tumours, which represent about 10-15% of
mediastinal tumours.3 Other extra-gonadal sites that can be
involved are the retroperitoneum and the pineal gland.5 The
exact pathogenesis of germ cell tumours in the mediastinum
is unclear. Several theories exist of which two have gained
wider acceptance.2 The germ cell theory proposed by
Friedman suggested that these tumours arise from germ cells
that migrated to the thymus during embryogenesis. He also
proposed that germ cells may be distributed to the thymus,
brain, liver and bone marrow. Schlumberger hypothesized
that the tumours arise due to an abnormality in thymic
development during embryogenesis.1,2 More recently Rosai
et al suggested that they may arise from myoid cells present
in the thymus.1
Seminomas are slow growing, bulky tumours that
invade locally early in the growth process. Patients may
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present with symptoms of compression of surrounding
structures, like dyspnoea, dysphagia, cough and chest pain, or
simply constitutional symptoms like fever and weight loss.
Uncommonly, mediastinal adenopathy and superior vena
cava syndrome may occur.2 About 20-30% of patients are
asymptomatic.1,2,6 Teratoma, primary large B cell lymphoma
and thymoma are other differential diagnosis.4
The most common sites of metastases of the tumour
are the lungs and regional lymph nodes. Other sites that have
been reported are the skeletal system, tonsils, thyroid gland,
spleen, skin, brain and spinal cord.2 Metastasis of testicular
seminomas to the mediastinum is rare and has been
documented in only a few cases.
Extragonadal germ cell tumours are histologically
similar to, but differ biologically and in clinical outcome from
their gonadal counterparts.3,7 Some distinguishing histologic
features, however, like remnants of thymic tissue and cystic
changes similar to multi-locular thymic cysts may be
identified in mediastinal seminomas.1 Diagnosis is by a
combination of radiographs, computed scans and tumour
markers (elevated alpha feto protein and beta HCG are
commonly found), and biopsy for histologic confirmation.
The overall survival rate for mediastinal seminomas is about
70-75%.1,2
Since a long time, radiotherapy with or without
surgery has been considered the primary modality of
treatment for seminomas because of their radiosensitive
characteristics.3 However this has been associated with a high
rate of recurrence with about one third of the patients
relapsing.8 Since both surgery and radiotherapy aim at
achieving local control, recently chemotherapy has been
advocated as the primary modality in treatment of
mediastinal seminomas. Some studies report long term
disease free intervals in about 85% of the patients receiving
chemotherapy, compared to 65% receiving radiotherapy.6
Before the availability of Cisplatin, the combination
chemotherapy of bleomycin and vinblastine was effective in
patients with non-seminomatous germ cell tumours but not in
seminomas.7 Given the rarity of primary mediastinal
seminomas, most studies are retrospective and contain cases
of both seminomatous and non seminomatous tumours.
However, they do show the effectiveness of chemotherapy in
seminomas after the introduction of Cisplatin.8
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Reported relapse rate of germ cell tumours with
Cisplatin based chemotherapy is approximately 6%.9
Cisplatin based chemotherapy along with Etoposide
and bleomycin is reported to have a cure rate of 90% in low
risk patiens and 70-80% in advanced seminoma, according to
the International Germ Cell Cancer Collaborative Group
Consensus Classification (IGCCCG). Prognosis is less clear
for patients in the intermediate risk group with liver and CNS
metastasis.10
In our patient BEP (Bleomycin, Etoposide, Cisplatin)
regimen chemotherapy proved successful with almost
complete resolution of his symptoms within 48 hours.
Residual mass was resected to assess response to
chemotherapy and to remove chemotherapy resistant disease.
Histopathology of the resected residual mass also did not
show any viable tumour. The patient was disease free until
last follow up.
Our case shows the successful outcome of using
Cisplatin based chemotherapy followed by debulking surgery
to treat primary mediastinal seminoma.
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